101 related articles for article (PubMed ID: 25222251)
21. Mll3 genetic variants affect risk of gastric cancer in the chinese han population.
Li B; Liu HY; Guo SH; Sun P; Gong FM; Jia BQ
Asian Pac J Cancer Prev; 2013; 14(7):4239-42. PubMed ID: 23991983
[TBL] [Abstract][Full Text] [Related]
22. VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer.
Lian L; Li XL; Xu MD; Li XM; Wu MY; Zhang Y; Tao M; Li W; Shen XM; Zhou C; Jiang M
BMC Cancer; 2019 Feb; 19(1):183. PubMed ID: 30819137
[TBL] [Abstract][Full Text] [Related]
23. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
24. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
25. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer.
Wang Y; Wang M
BMC Gastroenterol; 2016 Jul; 16(1):74. PubMed ID: 27457107
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.
Jin Z; Jiang W; Jiao F; Guo Z; Hu H; Wang L; Wang L
Int J Clin Exp Pathol; 2014; 7(9):5872-9. PubMed ID: 25337229
[TBL] [Abstract][Full Text] [Related]
30. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
[TBL] [Abstract][Full Text] [Related]
31. [KDM6A mutation and expression in gastric cancer are associated with prognosis].
Li LL; Huang ZG; Wang YW; Lu M; Hu KW
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):648-652. PubMed ID: 32867456
[No Abstract] [Full Text] [Related]
32. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
33. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
34. MOR1 expression in gastric cancer: a biomarker associated with poor outcome.
Yao YS; Yao RY; Zhuang LK; Qi WW; Lv J; Zhou F; Qiu WS; Yue L
Clin Transl Sci; 2015 Apr; 8(2):137-42. PubMed ID: 25441763
[TBL] [Abstract][Full Text] [Related]
35. SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis.
Maimaiti Y; Maimaitiming M; Li Y; Aibibula S; Ainiwaer A; Aili A; Sun Z; Abudureyimu K
BMC Gastroenterol; 2018 Jan; 18(1):12. PubMed ID: 29338701
[TBL] [Abstract][Full Text] [Related]
36. CD40 expression and its prognostic significance in human gastric carcinoma.
Guo J; Xiao JJ; Zhang X; Fan KX
Med Oncol; 2015 Mar; 32(3):63. PubMed ID: 25665853
[TBL] [Abstract][Full Text] [Related]
37. Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer.
Lee WS; Park YL; Kim N; Oh HH; Son DJ; Kim MY; Oak CY; Chung CY; Park HC; Kim JS; Myung DS; Cho SB; Joo YE
Int J Oncol; 2015 May; 46(5):2154-62. PubMed ID: 25672320
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
[TBL] [Abstract][Full Text] [Related]
39. High expression of heparanase-2 is an independent prognostic parameter for favorable survival in gastric cancer patients.
Zhang X; Xu S; Tan Q; Liu L
Cancer Epidemiol; 2013 Dec; 37(6):1010-3. PubMed ID: 24139593
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
